BALERNA, Switzerland--(BUSINESS WIRE)--APR Applied Pharma Research s.a. (“APR”), the Swiss, independent developer of patent protected, healthcare products, announces that new clinical data on an independent experience with Nexodyn™ in the treatment of difficult-to-heal chronic wounds have been presented by Elia Ricci, MD at the Fall Symposium of Advanced Wound Care in Las Vegas on Friday October 17th, 2014.
Help employers find you! Check out all the jobs and post your resume.
